🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
RATIONALE: Studying proteins in head and neck cancer cells in the laborator...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2005-05
Trial ID
NCT00896948
RATIONALE: Studying the effects of obatoclax mesylate in cell samples from ...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01150656
The study will reveal the transcriptomic signature linked to the aberrant a...
Status
Unknown
Location
Division of Clinical Immunology, Fondazione Policlinico Universitario A. Gemelli-IRCCS
Start Date
2021-07-29
Trial ID
NCT05754112
Treatments Being Tested
Background: \- Vaginal yeast infections are caused by a fungus called Cand...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-07-30
Trial ID
NCT01915251
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00899002
Background The current management on rectal cancer based on TNM staging has...
Status
Unknown
Location
Azienda Ospedale Università di Padova
Start Date
2020-01-01
Trial ID
NCT04917263
Treatments Being Tested
RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Hollings Cancer Center at Medical University of South Carolina
Start Date
2008-10
Trial ID
NCT00747305